How to conduct research on overdiagnosis. A keynote paper from the EGPRN May 2016, Tel Aviv

被引:12
作者
Brodersen, John [1 ,2 ,3 ]
机构
[1] Univ Copenhagen, Sect Gen Practice, Dept Publ Hlth, Fac Hlth Sci, Copenhagen, Denmark
[2] Univ Copenhagen, Res Unit Gen Practice, Dept Publ Hlth, Fac Hlth Sci, Copenhagen, Denmark
[3] Primary Hlth Care Res Unit, Region Zealand, Denmark
关键词
Overdiagnosis; overuse; overtreatment; qualitative research; quantitative research; PROSTATE-CANCER MORTALITY; SCREENING TRIAL; BREAST-CANCER; CONSEQUENCES; HARMS;
D O I
10.1080/13814788.2017.1290795
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Overdiagnosis is a growing problem worldwide. Overdiagnosis is the diagnosis of deviations, abnormalities, risk factors, and pathologies that in themselves would never cause symptoms (this applies only to risk factors and pathology), would never lead to morbidity, and would never be the cause of death. Overdiagnosis is often misinterpreted as overutilization or overtreatment. Overutilization, overtreatment, and overdiagnosis are interrelated but three distinct topics. Overutilization (establishment of standard practice that does not provide net benefit) does not have to lead to overdiagnosis or overtreatment, but the risk exists. Treatment of overdiagnosed conditions is one category of overtreatment. Another is when the best available evidence shows that the treatment has no beneficial effect. Overdiagnosis can be caused by overutilization and is nearly always followed by overtreatment. Treating an overdiagnosed condition cannot improve the patient's prognosis, and therefore can only be harmful. At the individual level, we can never be sure if the person is overdiagnosed. However, experiences and thoughts of individuals who are most likely overdiagnosed can be explored in qualitative interviews, e.g. men with a small screening detected abdominal aortic aneurism. In longitudinal surveys, the degree and length of psychosocial consequences associated with overdiagnosis can be estimated. In high-quality RCTs, the magnitude of overdiagnosis can be quantified, and in cohort studies, we can find indications of overdiagnosis. Finally, we can conduct research about the consequences of overdiagnosis in at least eight different areas: financial strain, hassles/inconveniences, medical costs, opportunity costs, physical harms, psychological harms, societal costs and work-related costs.
引用
收藏
页码:78 / 82
页数:5
相关论文
共 27 条
[1]   Korea's Thyroid-Cancer "Epidemic" - Screening and Overdiagnosis [J].
Ahn, Hyeong Sik ;
Kim, Hyun Jung ;
Welch, H. Gilbert .
NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (19) :1765-1767
[2]   Consequences of Screening in Breast Cancer (COS-BC): development of a questionnaire [J].
Brodersen, John ;
Thorsen, Hanne .
SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE, 2008, 26 (04) :251-256
[3]   Overdiagnosis: How cancer screening can turn indolent pathology into illness [J].
Brodersen, John ;
Schwartz, Lisa M. ;
Woloshin, Steven .
APMIS, 2014, 122 (08) :683-689
[4]   Long-Term Psychosocial Consequences of False-Positive Screening Mammography [J].
Brodersen, John ;
Siersma, Volkert Dirk .
ANNALS OF FAMILY MEDICINE, 2013, 11 (02) :106-115
[5]   Consequences of Screening in Lung Cancer: Development and Dimensionality of a Questionnaire [J].
Brodersen, John ;
Thorsen, Hanne ;
Kreiner, Svend .
VALUE IN HEALTH, 2010, 13 (05) :601-612
[6]   Quantifying and monitoring overdiagnosis in cancer screening: a systematic review of methods [J].
Carter, Jamie L. ;
Coletti, Russell J. ;
Harris, Russell P. .
BMJ-BRITISH MEDICAL JOURNAL, 2015, 350
[7]   The challenge of overdiagnosis begins with its definition [J].
Carter, S. M. ;
Rogers, W. ;
Heath, I. ;
Degeling, C. ;
Doust, J. ;
Barratt, A. .
BMJ-BRITISH MEDICAL JOURNAL, 2015, 350
[8]   Interpreting Overdiagnosis Estimates in Population-based Mammography Screening [J].
de Gelder, Rianne ;
Heijnsdijk, Eveline A. M. ;
van Ravesteyn, Nicolien T. ;
Fracheboud, Jacques ;
Draisma, Gerrit ;
de Koning, Harry J. .
EPIDEMIOLOGIC REVIEWS, 2011, 33 (01) :111-121
[9]  
Doust J, 2013, AUST FAM PHYSICIAN, V42, P856
[10]   Rethinking Screening for Breast Cancer and Prostate Cancer [J].
Esserman, Laura ;
Shieh, Yiwey ;
Thompson, Ian .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 302 (15) :1685-1692